KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $128.9 million.

  • Ginkgo Bioworks Holdings' Operating Expenses fell 1067.31% to $128.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $528.7 million, marking a year-over-year decrease of 3795.75%. This contributed to the annual value of $786.8 million for FY2024, which is 2948.94% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Operating Expenses of $128.9 million as of Q3 2025, which was down 1067.31% from $115.1 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Operating Expenses ranged from a high of $1.8 billion in Q4 2021 and a low of $101.2 million during Q1 2021
  • Its 5-year average for Operating Expenses is $374.4 million, with a median of $215.9 million in 2024.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Operating Expenses skyrocketed by 198449.39% in 2021, and later plummeted by 8204.54% in 2022.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Operating Expenses stood at $1.8 billion in 2021, then tumbled by 82.05% to $329.1 million in 2022, then tumbled by 35.33% to $212.9 million in 2023, then tumbled by 30.73% to $147.5 million in 2024, then dropped by 12.61% to $128.9 million in 2025.
  • Its Operating Expenses stands at $128.9 million for Q3 2025, versus $115.1 million for Q2 2025 and $137.3 million for Q1 2025.